The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of bifidobacterium longum ATCC BAAA-999.
1. A method of treating a patient having intestinal inflammation due to food allergies, the method comprising administering to the patient a nutritional composition comprising (i) Bifidobacterium longum ATCC BAA-999 in an amount from 10 8 to 10 12 cfu/g of the nutritional composition on a dry weight basis, (ii) a fat source that provides 5% to 55% of the energy of the nutritional composition, and (iii) a carbohydrate source that provides 40% to 80% of the energy of the nutritional composition.
2. The method of claim 1 , wherein the patient is a human.
3. A method of treating a patient having an illness selected from the group consisting of a reaction to a food allergen, chronic sub-clinical inflammation in the elderly, and inflammation where there is no underlying condition giving rise to the inflammation, the method comprising administering to the patient a nutritional composition comprising Bifidobacterium longum ATCC BAA-999 in an amount from 10 8 to 10 12 cfu/g of the nutritional composition on a dry weight basis, (ii) a fat source that provides 5% to 55% of the energy of the nutritional composition, and (iii) a carbohydrate source that provides 40% to 80% of the energy of the nutritional composition.
4. The method of claim 3 , wherein the illness of the patient is a reaction to a food allergen.
5. The method of claim 3 , wherein the patient is elderly, and the illness of the patient is chronic sub-clinical inflammation.
6. The method of claim 3 , wherein the illness of the patient is inflammation where there is no underlying condition giving rise to the inflammation.
7. The method of claim 3 , wherein the patient is a human.
8. A method of treating a patient having an illness selected from the group consisting of a reaction to a food allergen, chronic sub-clinical inflammation in the elderly, and inflammation where there is no underlying condition giving rise to the inflammation, the method comprising:
rendering Bifidobacterium longum ATCC BAA-999 non-replicating by a heat treatment at about 80° C. to about 110° C. for about 5 seconds to about 5 minutes; and
administering a nutritional composition to the patient, the nutritional composition comprising the non-replicating Bifidobacterium longum ATCC BAA-999 in an amount from 10 8 to 10 12 cfu/g of the nutritional composition on a dry weight basis, (ii) a fat source that provides 5% to 55% of the energy of the nutritional composition, and (iii) a carbohydrate source that provides 40% to 80% of the energy of the nutritional composition.
9. The method of claim 8 , wherein the patient is a human.